Myosin cardiac, full length, from porcine heart

€200.00

Fully functional.

Tested in actin activated phosphate release assay, motility assay.

Cardiac Myosin: The Motor Protein of the Heart

Cardiac myosin is a specialized motor protein responsible for heart muscle contraction. It is a class II myosin found in cardiomyocytes (heart muscle cells) and plays a crucial role in converting chemical energy from ATP into mechanical force to drive heartbeats.


Key Functions of Cardiac Myosin:

  1. Powers Heart Contraction: Generates force by interacting with actin filaments in the sarcomere.

  2. ATP Hydrolysis: Acts as an ATPase, breaking down ATP to produce energy for contraction.

  3. Regulates Contraction Speed: Different myosin heavy chain isoforms (α and β) control contraction velocity.

  4. Maintains Heart Efficiency: Balances energy use and force production to support continuous heart function.


Structural Components:

  • Myosin Heavy Chains (MHCs):

    • Contain the motor domain responsible for ATP binding and actin interaction.

    • Exist in two main isoforms:

      • α-Cardiac Myosin Heavy Chain (MYH6): Fast contraction, higher ATPase activity.

      • β-Cardiac Myosin Heavy Chain (MYH7): Slower contraction, more energy-efficient.

  • Myosin Light Chains (MLCs):

    • Stabilize the myosin head and regulate activity.

    • Include essential light chains (ELCs) and regulatory light chains (RLCs).


Cardiac Myosin vs. Other Myosin Types:

Myosin Type

Tissue Expression

Function

Cardiac Myosin

Heart muscle

Controls heart contractions

Skeletal Myosin

Skeletal muscle

Enables voluntary movements

Smooth Muscle Myosin

Blood vessels, intestines

Regulates involuntary contractions

Non-Muscle Myosin

Various tissues

Involved in cell motility and intracellular transport


Clinical Relevance of Cardiac Myosin:

  • Cardiomyopathies:

    • Mutations in MYH7 are linked to hypertrophic (HCM) and dilated (DCM) cardiomyopathies, which affect heart function.

  • Target for Heart Failure Drugs:

    • Myosin activators like Omecamtiv Mecarbil enhance contraction in heart failure patients.

    • Myosin inhibitors like Mavacamten are used to treat HCM by reducing excessive contractility.

  • Regenerative Medicine:

    • Research is exploring how modifying myosin expression can aid in heart repair and recovery.